Priya Kumthekar, MD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Other
    Ineligible company:
    Seagen
    Topic:
    Brain Metastases
    Date added:
    08/09/2023
    Date updated:
    08/09/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    Plus Therapeutics
    Topic:
    Leptomeningeal Metastases
    Date added:
    08/09/2023
    Date updated:
    08/09/2023
  • Attribution:
    Self
    Type of financial relationship:
    Consulting Fee
    Ineligible company:
    BPGBio
    Topic:
    Glioblastoma
    Date added:
    08/09/2023
    Date updated:
    08/09/2023
  • Attribution:
    Self
    Type of financial relationship:
    Contracted Research
    Ineligible company:
    Novocure
    Topic:
    Glioblastoma
    Date added:
    08/09/2023
    Date updated:
    08/09/2023

Pages

Return to 2023 2nd Inova Symposium on Multidisciplinary Management of Brain Tumors